We can help, call now: 1-520-783-6243
Toll free USA: 1-800-277-3132
Book Free Phone Session

Stem cell therapy for COPD

Treating COPD with stem cells

COPD, or chronic obstructive pulmonary disease, is a common respiratory disease in which the lungs become inflamed and narrow over time. It's caused by smoking, air pollution, and other factors such as genetics. Traditional treatment of those with severe COPD often involves lung volume reduction surgery or lung transplantation. 

Thankfully, stem cell therapies have been shown to be effective in treating this lung disease without resorting to these extreme measures.

Patients with chronic obstructive pulmonary disease (COPD) are facing 3 main concerns:

  • The lungs of COPD patients harbor chronic infections, leading to excessive mucous production, chest tightness, coughing, wheezing, and generalized fatigue.
  • Shallow difficult breathing and shortness of breath lead to poor oxygenation of tissues, causing systemic organ damage, congestion, and overall unwellness and pain.
  • Heavy metal toxicity and chronic inflammation are well known to worsen and prolong symptoms of COPD.

Regenerative stem cell therapy for COPD

The key goals of stem cell therapy for this condition is to repair lung tissue, oxygenate the whole body and help all tissues resolve the secondary symptoms.


COPD Treatment Plan

Our treatment plans generally last between 2 and 5 weeks, depending on your overall health, your condition, and the severity of your COPD symptoms. Anyone can sign up for stem cell treatment for COPD. Each stem cell treatment candidate will receive a tailored plan to help achieve the highest success rate for maximum therapy efficiency. Typically, stem cell therapy for COPD will resemble a program such as the one below, and will last for 4 weeks.


Stem cells

20 stem cell IVs



4 Plurisomes IVs


Peptides & Nutraceuticals

24 IVs



20 IVs



4 sessions


Physiotherapy & Massage

4 sessions


Benefits of stem cell therapy for COPD patients

Pluripotent stem cells have the ability to repair the lung tissue in those with chronic obstructive pulmonary disease, balance their immune system and recover the lost organ function that comes with poor oxygenation of tissue.

  • Reduced Inflammation

    The first benefit from stem cell treatment is immune regulation. Stem cells and their exosomes release immune and transcription factors that help immune cells to shift away from TH1 auto-immune reactivity. Clearing chronic infections and detoxifying the body of heavy metals helps to restore immune function. This calms the alveolar and lung tissue destruction in its tracts, paving way for continuous repair.

  • Improved Energy

    The second level of benefit is usually observed after a minimum of 6-12 injections when lung tissue begins repair via the delivery of stem cells’ anti-fibrotic and angiogenic factors. This in turn increases oxygen delivery to the lungs and to other organs, and usually feels like increased energy levels, improved strength, balance and coordination, decreased pain and the ability of think again.

  • Organ Function Restoration

    Pluripotent stem cells work on repairing not only lung tissue. They travel to all 220+ tissues of the body and gradually repair the systemic damage incurred from long-term poor organ oxygenation and perfusion. Heart function, circulation, digestion and other organ dysfunction continue to improve over time. Patients gradually become less and less dependent on extra oxygen delivery. Progress depends on how the severity of the overall condition.v

Keywords: lungs, COPD, stem cells copd, copd treatment, stem cell therapy, stem cell therapy for copd

1. Evaluation of pulmonary infiltrates in patients after stem cell transplantation - PubMed

2. A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD

3. Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic? - PubMed

4. Stem cell therapy for chronic obstructive pulmonary disease - PubMed

5. Stem cells and lung regeneration - PubMed

6. Human embryonic stem cells (hESCs) in the treatment of emphysematous COPD: a case report

See what our patients say about us